<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00945165</url>
  </required_header>
  <id_info>
    <org_study_id>09-3-028</org_study_id>
    <nct_id>NCT00945165</nct_id>
  </id_info>
  <brief_title>Exercise and Glycemic Control in Type 2 Diabetes</brief_title>
  <official_title>Defining the Optimal Exercise Program to Improve Glycemic Control in Various Stages of Type 2 Diabetes.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maastricht University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>ZonMw: The Netherlands Organisation for Health Research and Development</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Maastricht University Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hyperglycemia is an independent risk factor for the development of diabetic complications in
      type 2 diabetes. Exercise improves glycemic control, however, the role of exercise
      characteristics (e.g. intensity, type of exercise, timing, frequency) remains to be
      elucidated.

      This study aims to assess the effect of several exercise characteristics on hyperglycemia in
      various subgroups of type 2 diabetes patiÃ«nts.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2009</start_date>
  <completion_date type="Actual">June 2012</completion_date>
  <primary_completion_date type="Actual">April 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hyperglycemia</measure>
    <time_frame>24h</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mean Blood Glucose</measure>
    <time_frame>24h</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">124</enrollment>
  <condition>Diabetes Mellitus, Type 2</condition>
  <condition>Hyperglycemia</condition>
  <arm_group>
    <arm_group_label>Exercise</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>No exercise</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Exercise intervention</intervention_name>
    <description>various exercise characteristics</description>
    <arm_group_label>Exercise</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>No exercise</intervention_name>
    <description>No exercise control period</description>
    <arm_group_label>No exercise</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Impaired glucose tolerant subjects

        Inclusion Criteria:

          -  BMI 25 - 35 kg/m2

          -  Impaired Glucose Tolerant (according to ADA guidelines)

        Exclusion Criteria:

          -  Cardiac disease (cardiac event in the last 5 years)

          -  Type 2 diabetes

          -  Use of orale blood glucose lowering medication or exogenous insulin

          -  HbA1c &gt;10%

        Insulin treated type 2 diabetes patients

        Inclusion Criteria:

          -  BMI 25 - 35 kg/m2

          -  Insulin therapy

          -  diagnosed with type 2 diabetes &gt;2 yr

        Exclusion Criteria:

          -  Cardiac disease (cardiac event in the last 5 years)

          -  HbA1c &gt;10%

        Type 2 diabetes patients on oral blood glucose lowering medication

        Inclusion Criteria:

          -  BMI 25 - 35 kg/m2

          -  diagnosed with type 2 diabetes &gt;2 yr

        Exclusion Criteria:

          -  Cardiac disease (cardiac event in the last 5 years)

          -  HbA1c &gt;10%

          -  use of exogenous insulin
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jan-Willem M van Dijk, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Maastricht UMC</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Maastricht University Medical Centre</name>
      <address>
        <city>Maastricht</city>
        <state>Limburg</state>
        <zip>6200 MD</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <link>
    <url>http://www.m3-research.nl</url>
    <description>Website Muscle Metabolism Maastricht</description>
  </link>
  <verification_date>October 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 23, 2009</study_first_submitted>
  <study_first_submitted_qc>July 23, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 24, 2009</study_first_posted>
  <last_update_submitted>October 24, 2012</last_update_submitted>
  <last_update_submitted_qc>October 24, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 25, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Continuous Glucose Monitoring System</keyword>
  <keyword>Exercise</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
    <mesh_term>Hyperglycemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

